VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.

Xactware, Verisk property estimation software and claims tools help property restoration and insurance industry professionals strengthen operating efficiency, improve underwriting and claims ...

Vertex, Inc. VERX reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance on ...

Investors with a lot of money to spend have taken a bullish stance on Vertex Pharmaceuticals VRTX. And retail traders should ...

If you plan on repairing or maintaining your motorcycle at home, you're going to want a solid motorcycle tool kit at the ready. That means a kit that not only includes all of the tools you'll ...

Tool have just announced Live in the Sand, their very own destination festival taking place in 2025 with an impressive lineup. The three-day event will be include a five-star all-inclusive ...

Google Cloud is enabling general availability for its Vertex AI platform in addition ... optimistic and welcome the introduction of AI as a tool that can potentially help mitigate these burdens.

Vertex has reported phase 3 data on its near-approval pain drug candidate suzetrigine, shedding light on how the non-opioid painkiller combines with ibuprofen and why the prospect failed to match ...

Vertex's diverse pipeline, including Casgevy for SCD, suzetrigine for chronic pain, and the vanzacaftor triple for CF, positions it for growth despite launch challenges. Casgevy's complex ...

So when a business like Vertex Pharmaceuticals (NASDAQ: VRTX) releases some new data on a potential blockbuster that could be just a few months away from being approved for sale, it's a big ...